Table 1.13

Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years

Survival (%)

Organ and Survival Type Follow-up Period
3 Months 1 Year 3 Years 5 Years 10 Years
Tx 2003-2004 Tx 2003-2004 Tx 2001-2004 Tx 1999-2004 Tx 1994-2004
Kidney: Deceased Donor Graft Survival 94.3% 89.5% 78.6% 67.1% 40.8%
Patient Survival 97.9% 94.7% 88.1% 80.7% 60.7%
Kidney: Living Donor Graft Survival 97.2% 95.1% 88.4% 80.3% 56.5%
Patient Survival 99.2% 98.0% 94.5% 90.4% 76.4%
Pancreas Alone Graft Survival 87.5% 72.8% 58.4% 53.4% 25.9%
Patient Survival 97.9% 94.9% 91.6% 90.2% 66.9%
Pancreas After Kidney Graft Survival 86.7% 78.7% 67.3% 56.4% 27.6%
Patient Survival 98.3% 95.5% 89.9% 83.6% 60.6%
Kidney-Pancreas Kidney Graft Survival 95.5% 91.8% 85.1% 76.3% 53.5%
Pancreas Graft Survival 89.2% 85.2% 79.3% 71.1% 54.5%
Patient Survival 97.7% 95.1% 90.8% 85.8% 69.2%
Liver: Deceased Donor Graft Survival 89.6% 82.4% 73.6% 67.4% 53.0%
Patient Survival 93.2% 86.9% 79.0% 73.4% 59.4%
Liver: Living Donor Graft Survival 90.0% 84.0% 76.0% 68.8% 66.5%
Patient Survival 95.8% 91.2% 82.9% 76.8% 76.2%
Intestine Graft Survival 88.3% 78.5% 50.6% 40.1% 27.9%
Patient Survival 93.2% 87.5% 62.2% 50.2% 40.6%
Heart Graft Survival 92.0% 87.5% 79.4% 72.6% 51.5%
Patient Survival 92.5% 88.1% 80.2% 73.7% 53.4%
Lung Graft Survival 92.5% 83.3% 64.4% 48.9% 23.4%
Patient Survival 93.2% 84.9% 66.4% 51.6% 25.6%
Heart-Lung Graft Survival 75.2% 64.1% 53.1% 41.5% 26.5%
Patient Survival 77.8% 66.7% 53.8% 43.6% 27.3%
Kidney-Liver Kidney Graft Survival 88.3% 79.5% 69.1% 60.9% 45.5%
Liver Graft Survival 88.7% 79.9% 70.5% 64.5% 49.5%
Patient Survival 92.1% 84.7% 75.1% 68.9% 54.5%
Kidney-Heart Heart Graft Survival 88.0% 83.9% 81.9% 73.6% 43.6%
Kidney Graft Survival 88.0% 83.8% 83.7% 74.2% 33.4%
Patient Survival 86.8% 81.1% 83.3% 76.7% 46.2%
Liver-Intestine Intestine Graft Survival 82.4% 69.1% 56.7% 50.1% 35.1%
Liver Graft Survival 82.4% 69.1% 57.8% 51.1% 35.0%
Patient Survival 83.1% 69.2% 62.8% 54.8% 37.5%


Source: OPTN/SRTR Data as of May 1, 2006.

Multi-organ transplants are excluded except where specified. Living donor transplants excluded unless explicitly listed. Heterotopic heart and liver transplants excluded.

Graft survival follows individual transplants until graft failure. Patient survival follows patients from first transplant of this type until death.